| Literature DB >> 1972432 |
D P Geaney1, N Soper, B J Shepstone, P J Cowen.
Abstract
Patients with Alzheimer disease (AD) had reduced regional cerebral blood flow (rCBF) in the posterior parietotemporal region compared with controls, as determined with technetium-99m hexamethyl propyleneamine oxime and single photon emission tomography. Central cholinergic stimulation with physostigmine produced a focal increase in rCBF in the posterior parietotemporal region in the patients with AD but not in controls.Entities:
Mesh:
Substances:
Year: 1990 PMID: 1972432 DOI: 10.1016/0140-6736(90)93028-n
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321